Area of expertise: Antibacterial drug resistance mechanisms
Anthony Maxwell
Group Leader
John Innes Centre
more
Ronan McCarthy
Professor of Biomedical Sciences
Brunel University of London, UK
more
Alita Miller
Vice President of Biology
Entasis Therapeutics
more
Ian Morrissey
Chief Scientific and Development Officer
IHMA Europe Sàrl
more
Rolf Müller
Managing Director
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
more
Alex O’Neill
Professor
University of Leeds
more
Malcolm Page
Formerly Roche, Switzerland
more
Michael Pucci
Executive Director, Early Drug Discovery
Spero Therapeutics
more
Daniel Ritz
Senior Director and Senior Group Leader
Idorsia Pharmaceuticals
more
Carole Sable
Principle
CA Sable Consulting, LLC
more